1346541-01-2 Usage
Explanation
The compound consists of 11 carbon atoms, 11 hydrogen atoms, 3 fluorine atoms, and 1 nitrogen atom.
Explanation
It is a modified version of the pyridine molecule, with specific substituents attached to the ring.
Explanation
2-(tert-butyl)-6-(trifluoromethyl)pyridine is commonly used as a starting material or building block in the production of various drugs and agricultural chemicals.
Explanation
It is a liquid without any color, which indicates the lack of strong chromophores in its molecular structure.
Explanation
The compound changes from liquid to gas at a temperature range of 178 to 180 degrees Celsius.
Explanation
The mass of the compound per unit volume is 1.118 grams per milliliter, which is slightly greater than water's density.
Explanation
The compound has a pleasant, mild scent reminiscent of flowers and sweetness.
Explanation
The compound can easily catch fire or ignite, and proper precautions should be taken to prevent fires or explosions.
Explanation
Contact with the compound may cause irritation or damage to the skin and eyes, so appropriate handling and protective measures are necessary.
Type of compound
Pyridine derivative
Usage
Intermediate in the synthesis of pharmaceuticals and agrochemicals
Physical state
Colorless liquid
Boiling point
178-180°C
Density
1.118 g/mL
Odor
Mild, sweet, floral
Flammability
Flammable
Health hazards
Skin and eye irritation
Check Digit Verification of cas no
The CAS Registry Mumber 1346541-01-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,5,4 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1346541-01:
(9*1)+(8*3)+(7*4)+(6*6)+(5*5)+(4*4)+(3*1)+(2*0)+(1*1)=142
142 % 10 = 2
So 1346541-01-2 is a valid CAS Registry Number.
1346541-01-2Relevant academic research and scientific papers
PYRROLO SULFONAMIDE COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORGAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
-
, (2012/11/06)
The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administrating these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolo sulfonamide compounds of Formula (1) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof.
